Business Context and Reporting Period
This Form 6-K filing by Mdxhealth SA covers the month of November 2022, with the report dated November 29, 2022. The filing serves to furnish a press release (Exhibit 99.1) issued by the Company on the same date. The registrant is a foreign private issuer incorporated in Belgium.
Key Financial Metrics
The filing text does not provide specific financial data. No values for revenue, profit, cash flow, margins, debt, or liquidity are disclosed in this document.
Material Changes
The filing does not contain comparative financial data or details regarding material changes versus prior periods. The document solely references the issuance of a press release.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in the body of this Form 6-K. The content refers readers to the attached press release (Exhibit 99.1) for the substance of the announcement. The filing explicitly states that the information in the exhibit is furnished and not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Press Release) for the specific details of the announcement made on November 29, 2022.
- Verify the legal status of the information, noting it is furnished but not "filed" under Section 18 of the Exchange Act.
- Confirm the identity of the signatory: Michael McGarrity, Chief Executive Officer.
- Check subsequent filings for any financial updates or detailed disclosures related to the press release topic.